At $147.89 ILMN still has a whopping PSR (Price Sales Ratio) of 13.62, but Illumina is a genomics leader and I believe we've only recently entered into the Age of Genomics.
On 02014.03.26 Yahoo! Finance is showing ILMN's SIR (Short Interest Ratio) at 11.6, which I consider high.
No comments:
Post a Comment